Multimodal Mass Spectrometry Identifies a Conserved Protective Epitope in S. pyogenes Streptolysin O

peer-reviewed · Analytical Chemistry · 2024

peer-reviewed · Analytical Chemistry · 2024. Di Tang et al. High Resolution Image Download MS PowerPoint Slide An important element of antibody-guided vaccine design is…
Date 2024-05-03
Type peer-reviewed
Venue Analytical Chemistry
Publisher American Chemical Society
Contribution downstream-application
DOI 10.1021/acs.analchem.4c00596
Citations (OpenAlex) 11
Venue 2-year citedness 6.29

Abstract

High Resolution Image Download MS PowerPoint Slide An important element of antibody-guided vaccine design is the use of neutralizing or opsonic monoclonal antibodies to define protective epitopes in their native three-dimensional conformation. Here, we demonstrate a multimodal mass spectrometry-based strategy for in-depth characterization of antigen–antibody complexes to enable the identification of protective epitopes using the cytolytic exotoxin Streptolysin O (SLO) from Streptococcus pyogenes as a showcase. We first discovered a monoclonal antibody with an undisclosed sequence capable of neutralizing SLO-mediated cytolysis. The amino acid sequence of both the antibody light and the heavy chain was determined using mass-spectrometry-based de novo sequencing, followed by chemical cross-linking mass spectrometry to generate distance constraints between the antibody fragment antigen-binding region and SLO. Subsequent integrative computational modeling revealed a discontinuous epitope located in domain 3 of SLO that was experimentally validated by hydrogen–deuterium exchange mass spectrometry and reverse engineering of the targeted epitope. The results show that the antibody inhibits SLO-mediated cytolysis by binding to a discontinuous epitope in domain 3, likely preventing oligomerization and subsequent secondary structure transitions critical for pore-formation. The epitope is highly conserved across >98% of the characterized S. pyogenes isolates, making it an attractive target for antibody-based therapy and vaccine design against severe streptococcal infections.

Authors

  1. Di Tang · Lund University
  2. Carlos Gueto-Tettay · Lund University
  3. Elisabeth Hjortswang · Lund University
  4. Joel Ströbaek · Lund University
  5. Simon Ekström · Lund University
  6. Lotta Happonen · Lund University
  7. Lars Malmström · Lund University
  8. Johan Malmström · Lund University

Methods and tools

  • Streptolysin O epitope de novo workflow: Multi-modal MS workflow combining three deep-learning de novo sequencers (PointNovo, Casanovo, InstaNovo) with antibody profiling to identify a conserved protective epitope in Streptococcus pyogenes Streptolysin O.

Cited by (1)

Seen in the charts

Back to the full map

Back to top